Search Results - "Skalweit, Marion J."
-
1
Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Published in Antimicrobial Agents and Chemotherapy (01-11-2012)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Substitutions at Position 105 in SHV Family β-Lactamases Decrease Catalytic Efficiency and Cause Inhibitor Resistance
Published in Antimicrobial Agents and Chemotherapy (01-11-2012)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
N152G, -S, and -T Substitutions in CMY-2 β-Lactamase Increase Catalytic Efficiency for Cefoxitin and Inactivation Rates for Tazobactam
Published in Antimicrobial Agents and Chemotherapy (01-04-2013)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
Penicillin Sulfone Inhibitors of Class D β-Lactamases
Published in Antimicrobial Agents and Chemotherapy (01-04-2010)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Outpatient Parenteral Antibiotic Therapy in Older Adults
Published in Infectious disease clinics of North America (01-03-2023)“…Outpatient parenteral antimicrobial therapy (OPAT) for older adults is a complex process that involves multiple stakeholders and care coordination, but it is a…”
Get full text
Journal Article -
6
Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update
Published in Infectious disease clinics of North America (01-12-2020)“…This article reviews antibiotic resistance and treatment of bacterial infections in the growing number of patients who are immunocompromised: solid organ…”
Get full text
Journal Article -
7
An unusual case of underlying rilpivirine resistance in an antiretroviral-naïve man with AIDS
Published in International journal of STD & AIDS (01-12-2016)“…Primary resistance mutations to second generation HIV non-nucleoside reverse transcriptase inhibitors are rare in HIV-infected persons in the US (estimated at…”
Get more information
Journal Article -
8
A rare case of immune reconstitution inflammatory syndrome presenting as secondary syphilis
Published in International journal of STD & AIDS (01-09-2015)“…Immune reconstitution syndrome has rarely been reported in the context of syphilis infection. We report a patient with AIDS (CD4 42 cells/mm(3), viral load…”
Get more information
Journal Article -
9
Effect of asparagine substitutions in the YXN loop of a class C β-lactamase of Acinetobacter baumannii on substrate and inhibitor kinetics
Published in Antimicrobial agents and chemotherapy (01-03-2015)“…Class C cephalosporinases are a growing threat, and inhibitors of these enzymes are currently unavailable. Studies exploring the YXN loop asparagine in the…”
Get full text
Journal Article -
10
Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
Published in Drug design, development and therapy (01-01-2016)“…Genetic screening of (PSDA) and (ACB) reveals genes that confer increased susceptibility to β-lactams when disrupted, suggesting novel drug targets. One such…”
Get full text
Journal Article -
11
Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
Published in Drug design, development and therapy (01-01-2015)“…Drug-resistant pathogens have gained a foothold especially in the most vulnerable patient populations, hospitalized and immunocompromised individuals…”
Get full text
Journal Article -
12
Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection
Published in Open forum infectious diseases (01-07-2018)“…Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase approved for the treatment of B-cell malignancies. There is growing concern about the risk…”
Get full text
Journal Article -
13
Mycobacterial Tenosynovitis After Sea Urchin Spine Injury in an Immunocompromised Patient
Published in Open forum infectious diseases (01-11-2018)Get full text
Journal Article -
14
Enhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2
Published in Biochemistry (Easton) (09-02-2010)“…The biochemical properties of CMY-32, a class C enzyme possessing a single-amino acid substitution in the Ω loop (Gly214Glu), were compared to those of the…”
Get full text
Journal Article -
15
SAME is different: a case report and literature review of Staphylococcus aureus metastatic endophthalmitis
Published in Southern medical journal (Birmingham, Ala.) (01-09-2009)“…We present a case of methicillin-sensitive Staphylococcus aureus metastatic endophthalmitis (SAME) that developed from a bacteremia. We compare this to a…”
Get full text
Journal Article -
16
The Importance of the trans-Enamine Intermediate as a β-Lactamase Inhibition Strategy Probed in Inhibitor-Resistant SHV β-Lactamase Variants
Published in ChemMedChem (01-06-2012)“…The ability of bacteria to express inhibitor‐resistant (IR) β‐lactamases is stimulating the development of novel inhibitors of these enzymes. The…”
Get full text
Journal Article -
17
Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host
Published in Infectious disease clinics of North America (01-12-2020)“…This article reviews antibiotic resistance and treatment of bacterial infections in the growing number of patients who are immunocompromised: solid organ…”
Get full text
Journal Article -
18
-
19
Bulgecin A as a β-lactam enhancer for carbapenem-resistantPseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
Published in Drug design, development and therapy (01-01-2016)“…Genetic screening of Pseudomonas aeruginosa (PSDA) and Acinetobacter baumannii (ACB) reveals genes that confer increased susceptibility to β-lactams when…”
Get full text
Journal Article -
20
715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
Published in Open forum infectious diseases (23-10-2019)“…Abstract Background Genetic screening of ACB has revealed genes that confer increased susceptibility to β-lactams when these genes are disrupted suggesting…”
Get full text
Journal Article